Skip to main content
Clinical Trials/NCT02431741
NCT02431741
Completed
Not Applicable

Title: A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds

Molnlycke Health Care AB2 sites in 1 country14 target enrollmentOctober 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Malignant Wounds
Sponsor
Molnlycke Health Care AB
Enrollment
14
Locations
2
Primary Endpoint
Infection in the Wound (Signs of Clinical Infection)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This is a prospective, open, non-controlled clinical investigation to evaluate the performance and safety of using Mepilex Transfer Ag on a malignant wound. Approximately ten to fifteen (10-15) subjects from one to three centers in Europe, presenting with a malignant (fungating) wound will be enrolled into the study. Eligible subjects will have one malignant (fungating) wound selected as a "study site". Subjects will be followed for a one-week observation period with their existing product followed by a 4-week investigation period using Mepilex Transfer Ag.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
December 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Molnlycke Health Care AB
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
  • Both genders with an age ≥ 18 years at randomization
  • Subjects with a suspected survival time of \> 3 months
  • Signed informed consent

Exclusion Criteria

  • Any known or suspected systemic infection
  • Use of metronidazole is not allowed during the investigation period
  • Any known sensitivity to silver or other components/products used in this study.
  • Major uncontrolled systemic disorders such as hepatic, renal, neurologic, or endocrinologic disorders.
  • Participation in another investigational study while participating in this study.

Outcomes

Primary Outcomes

Infection in the Wound (Signs of Clinical Infection)

Time Frame: weekly, for 5 weeks

Weekly Visual inspection of the wounds by the investigators.

Study Sites (2)

Loading locations...

Similar Trials